AKEBIA THERAPEUTICS, INC. Reclassifications of Temporary to Permanent Equity
AKEBIA THERAPEUTICS, INC. (AKBA) reported Reclassifications of Temporary to Permanent Equity of $2.49 million for the 12-month period ending 2013-12-31, per its 10-K filed 2015-03-04.
Discontinued › Shareholders' Equity
us-gaap:ReclassificationsOfTemporaryToPermanentEquity · last filed 2015-03-04
- AKEBIA THERAPEUTICS, INC. reclassifications of temporary to permanent equity for the quarter ending 2013-12-31 was $0.00.
- AKEBIA THERAPEUTICS, INC. reclassifications of temporary to permanent equity for fiscal 2013 was $2.49M.
| Period end | Reclassifications of Temporary to Permanent Equity 3 month | Reclassifications of Temporary to Permanent Equity 9 month | Reclassifications of Temporary to Permanent Equity 12 month |
|---|---|---|---|
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-04 | $2.49M 10-K · filed 2015-03-04 | |
| 2013-09-30 | $2.49M 10-Q · filed 2014-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Greenwich LifeSciences, Inc. (GLSI) | United States | $0.267B | -15.02 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Mereo BioPharma Group plc (MREO) | $0.269B | -9.41 | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |